Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study

Overview of attention for article published in BMC Pulmonary Medicine, May 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study https://t.co/8zqqYMUxU3 #lungcancer #oncology https://t.co/L8iUV92A6A

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.